文献速递安宁疗护多重用药认知障碍与谵妄

养老院房颤居民临终关怀入组前口服抗凝药停用情况

Discontinuation of oral anticoagulant use among nursing home residents with atrial fibrillation before hospice enrollment.
PubMed 文献 · J Am Geriatr Soc · 2023-07-19

本研究基于美国3万余例养老院房颤居民数据,发现45.7%在临终关怀入组前停用口服抗凝药;体重不足、高出血风险及中重度认知障碍者停药率更高,而静脉血栓栓塞、他汀使用及多重用药者停药率较低。

要点

  • 近半数养老院房颤居民在临终关怀入组前停用口服抗凝药。
  • 高出血风险、体重不足及认知障碍者更倾向于停药。
  • 静脉血栓栓塞、他汀使用及多重用药者停药可能性较低。

核心结论

  • 养老院房颤居民在临终关怀入组前常停用抗凝药,但决策并非仅由净临床获益驱动。

主要发现

  • 45.7%的近期口服抗凝药使用者在临终关怀入组前停药。
  • 体重不足者停药aPR为1.02(95%CI 1.01-1.03),高出血风险者为1.04(95%CI 1.03-1.05),中重度认知障碍者为1.02(95%CI 1.02-1.03)。
  • 静脉血栓栓塞者停药aPR为0.94(95%CI 0.93-0.96),他汀使用者为0.88(95%CI 0.87-0.89),多重用药(≥10种药物)者为0.72(95%CI 0.71-0.73)。

临床怎么用

  • 对临终关怀入组前的养老院房颤居民,应综合评估净临床获益、出血风险及认知状态后个体化决策抗凝药停用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Oral anticoagulants (OACs) are effective in reducing the risk of cardioembolic stroke due to atrial fibrillation. While most nursing home residents with atrial fibrillation qualify for anticoagulation based on clinical guidelines, the net clinical benefits of OACs may diminish as residents approach the end of life. METHODS: We conducted a cross-sectional study of 30,503 US nursing home residents with atrial fibrillation (based on Minimum Data Set 3.0 and Medicare Part A records) who used OACs in the year before enrolling in hospice care during 2012-2016. Whether residents discontinued OACs before hospice enrollment was determined using Part D claims and date of hospice enrollment. Modified Poisson models estimated adjusted prevalence ratios (aPR). RESULTS: Almost half (45.7%) of residents who had recent OAC use discontinued prior to hospice enrollment. Residents who were underweight (aPR: 1.02; 95% confidence interval [CI]: 1.01-1.03), those with high bleeding risk (aPR: 1.04, 95% CI: 1.03-1.05), and those with moderate or severe cognitive impairment (aPR: 1.02, 95% CI: 1.02-1.03) had a higher prevalence of OAC discontinuation before entering hospice. Residents with venous thromboembolism (aPR: 0.94, 95% CI: 0.93-0.96), statin users (aPR: 0.88, 95% CI: 0.87-0.89), and those on polypharmacy (≥10 medications, aPR: 0.72; 95% CI: 0.71-0.73) were less likely to discontinue OACs before enrollment in hospice. CONCLUSION: Anticoagulants are often discontinued among older nursing home residents with atrial fibrillation before hospice enrollment; it is not clear that these decisions are driven solely by net clinical benefit considerations. Further research is needed on comparative outcomes to inform resident-centered decisions regarding OAC use in older adults entering hospice.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Chen Q, Baek J, Goldberg R, et al. Discontinuation of oral anticoagulant use among nursing home residents with atrial fibrillation before hospice enrollment. J Am Geriatr Soc. 2023. PMID: 37466267. doi:10.1111/jgs.18512

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。